outputs are generated in a format suitable for CSR integration.

1. Schedule a CSR kick-off meeting with writing, statistical, and clinical stakeholders.
2. Align on SAP finalization, mock shells, and any planned subgroup analyses.
3. Discuss timelines for TLF generation and QA review processes.

Define Responsibilities Clearly:

Use a Responsibility Assignment Matrix (RACI) to clarify who owns what:

• Biostatistician: Provides and verifies TLFs, SAP references, and efficacy/safety calculations
• Medical Writer: Drafts narrative sections, integrates results, and interprets findings in plain language
• Clinical Lead: Reviews clinical context and supports discussion development

These roles should be documented in the writing plan to comply with pharmaceutical SOP guidelines.

Integrating Statistical Outputs into the CSR:

Key sections where biostatistical input is crucial include:

1. Study Objectives and Endpoints: Verify that primary/secondary endpoints match the protocol and SAP
2. Subject Disposition: Use enrollment, screen failure, and discontinuation data directly from listings
3. Baseline Characteristics: Present demographic and medical history summaries
4. Efficacy and Safety Results: Collaborate on the exact wording of statistical findings, p-values, and confidence intervals
5. Protocol Deviations: Discuss how major deviations were defined and handled statistically

Ensure that each table or figure referenced is version-controlled and stored in systems compliant with process validation standards.

Reviewing Statistical Analysis Plans (SAPs):

The SAP is your primary reference for the statistical methods used. Work with your biostatistician to:

• Clarify complex methodologies (e.g., non-inferiority margins, ANCOVA models)
• Understand any post-hoc analyses included
• Resolve any deviations from the pre-specified plan

All deviations from the SAP should be transparently documented in the CSR’s “Changes to Planned Analysis” section to avoid queries from agencies like the EMA.

Common Challenges and Solutions:

• Challenge: Tables delivered late or in incorrect format
  Solution: Use shared timelines and test mock shells to verify structure early.
• Challenge: Misinterpretation of statistical data by writers
  Solution: Use comment threads or shared documents to verify interpretation with statisticians.
• Challenge: Inconsistent phrasing across sections
  Solution: Create a master glossary of statistical terms and preferred expressions.

Document these practices using pharma regulatory requirements SOPs to ensure audit readiness.

Tools That Facilitate Collaboration:

• MS Teams or Slack for real-time discussion and clarifications
• SharePoint or Veeva Vault for version control of TLFs and drafts
• Review tools like Acrobat Pro or TrackChanges in Word for commenting
• Collaborative documents (Google Docs, Office 365) for simultaneous edits

Use structured templates and version-controlled environments to align with documentation practices endorsed by CDSCO.

Maintaining Data Consistency Across Documents:

Ensure the same data is consistently used in the:

• CSR body
• Summary documents (Module 2.5 and 2.7 of CTD)
• Lay summary
• Integrated Summary of Safety (ISS) and Efficacy (ISE)

Biostatisticians should validate the final integrated datasets and confirm accuracy across these deliverables.

Conclusion:

Collaboration with biostatisticians is essential for delivering a compliant and scientifically sound CSR. By establishing communication protocols, using shared templates, and validating data interpretations, medical writers can enhance quality, reduce rework, and accelerate submission timelines.

Fostering a culture of collaboration between writers and statisticians not only improves documentation integrity but also increases the chances of successful regulatory approval.